JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talbot, P. S.
Right arrow Articles by Hwang, D.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talbot, P. S.
Right arrow Articles by Hwang, D.-R.

11C-GR103545, a Radiotracer for Imaging{kappa}-Opioid Receptors In Vivo with PET: Synthesis and Evaluation in Baboons

Peter S. Talbot, MD1, Raj Narendran, MD1, Eduardo R. Butelman, PhD2, Yiyun Huang, PhD1,3, Kim Ngo, BS1, Mark Slifstein, PhD1, Diana Martinez, MD1, Marc Laruelle, MD1,3 and Dah-Ren Hwang, PhD1

1 Department of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York
2 Laboratory on the Biology of Addictive Diseases, Rockefeller University, New York, New York
3 Department of Radiology, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York



View larger version (19K):

[in a new window]
 
FIGURE 1. Preparation of GR103545 and the chiral precursor 7. Reaction conditions: (a) thionyl chloride (SOCl2), methanol; (b) N-Boc-N-Bz-NBz-glycine, N,N-dicyclohexylcarbodiimide; (c) SOCl2; (d) lithium aluminum hydride; (e) 3,4-dichlorophenylacetyl chloride; (f) dimethyl sulfoxide, oxalyl chloride, morpholine; (g) pyrrolidine, HCl/methanol, pH 6; (h) sodium cyanoboronhydride3; (i) H2/Pd/C; (j) methyl chloroformate.

 


View larger version (15K):

[in a new window]
 
FIGURE 2. (A) Chiral HPLC separation of optical isomers of compound 7, showing R-(+)-isomer of 7, S-(–)-isomer of 7, and racemic (±) isomers of 7. HPLC conditions: column, Chiralcel OD (250 x 4.6 mm); solvent, 25%:75%:0.01% isopropanol:hexane:diethylamine; flow rate, 2 mL/min. (B) Chiral HPLC separation of optical isomers of GR89695, showing GR103545 (the (–)-isomer) and GR89695 (the racemic isomers). HPLC conditions: column, Chiralcel OD (250 x 4.6 mm); solvent, 20%:80%:0.01% isopropanol:hexane:diethylamine; flow rate, 2 mL/min.

 


View larger version (72K):

[in a new window]
 
FIGURE 3. (A) Sagittal (left), coronal (middle), and transverse (right) slices of representative baboon PET scan acquired from 40 to 80 min after injection of 11C-GR103545. Activity is concentrated in cingulate, frontal, temporal, and parietal cortices; medial temporal lobe; and striatum. Little activity is seen in brain stem and occipital cortex. Cerebellar uptake appears close to background level. (B) 11C-GR103545 scans (same slices in same baboon over same interval) after pretreatment with naloxone, 1 mg/kg intravenously. Images in A and B are normalized to their respective injected doses of activity and displayed with same intensity range. (C) Coregistered MR images of same baboon.

 


View larger version (23K):

[in a new window]
 
FIGURE 4. Time–activity curves in selected brain regions from single, representative study after bolus injection of 11C-GR103545: cerebellar ({circ}), occipital ({diamondsuit}), frontal ({triangleup}), parietal ({blacksquare}), and cingulate (•). Points are measured values; lines are values fitted to a 2-tissue-compartment model. ID = injected dose.

 


View larger version (17K):

[in a new window]
 
FIGURE 5. Mean regional V3'' values for 11C-GR103545 at baseline and after pretreatment with naloxone, 1 mg/kg intravenously (n = 3). Error bars = SD. After naloxone, regional V3'' values are significantly reduced (repeated-measures ANOVA, P < 0.001) and approach homogeneous low-to-negligible levels. BSTM = brain stem; THA = thalamus; STR = striatum; MTL = medial temporal lobe; CIN = cingulate cortex; FNT = frontal cortex; TEM = temporal cortex; PAR = parietal cortex; OCC = occipital cortex.

 


View larger version (32K):

[in a new window]
 
FIGURE 6. Time–activity curves in selected brain regions from 4 experiments performed on baboon A: cerebellar ({circ}), occipital ({diamondsuit}), frontal ({triangleup}), parietal ({blacksquare}), and cingulate (•). (A) Racemic 11C-GR89696. (B) 11C-GR89696 after pretreatment with naloxone. (C) The active enantiomer 11C-GR103545. (D) The inactive enantiomer (+)- 11C-GR89696. Points are measured values; lines are values fitted to a 2-tissue-compartment model. ID = injected dose.

 


View larger version (22K):

[in a new window]
 
FIGURE 7. Comparison between 11C-GR103545 (n = 3) and 11C-carfentanil (n = 9) regional V3'' values in same baboons. BSTM = brain stem; THA = thalamus; STR = striatum; MTL = medial temporal lobe; CIN = cingulate cortex; FNT = frontal cortex; TEM = temporal cortex; PAR = parietal cortex; OCC = occipital cortex.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.